Literature DB >> 11027272

Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

C D Lopez1, Y Ao, L H Rohde, T D Perez, D J O'Connor, X Lu, J M Ford, L Naumovski.   

Abstract

p53 is an important mediator of the cellular stress response with roles in cell cycle control, DNA repair, and apoptosis. 53BP2, a p53-interacting protein, enhances p53 transactivation, impedes cell cycle progression, and promotes apoptosis through unknown mechanisms. We now demonstrate that endogenous 53BP2 levels increase following UV irradiation induced DNA damage in a p53-independent manner. In contrast, we found that the presence of a wild-type (but not mutant) p53 gene suppressed 53BP2 steady-state levels in cell lines with defined p53 genotypes. Likewise, expression of a tetracycline-regulated wild-type p53 cDNA in p53-null fibroblasts caused a reduction in 53BP2 protein levels. However, 53BP2 levels were not reduced if the tetracycline-regulated p53 cDNA was expressed after UV damage in these cells. This suggests that UV damage activates cellular factors that can relieve the p53-mediated suppression of 53BP2 protein. To address the physiologic significance of 53BP2 induction, we utilized stable cell lines with a ponasterone A-regulated 53BP2 cDNA. Conditional expression of 53BP2 cDNA lowered the apoptotic threshold and decreased clonogenic survival following UV irradiation. Conversely, attenuation of endogenous 53BP2 induction with an antisense oligonucleotide resulted in enhanced clonogenic survival following UV irradiation. These results demonstrate that 53BP2 is a DNA damage-inducible protein that promotes DNA damage-induced apoptosis. Furthermore, 53BP2 expression is highly regulated and involves both p53-dependent and p53-independent mechanisms. Our data provide new insight into 53BP2 function and open new avenues for investigation into the cellular response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027272      PMCID: PMC86412          DOI: 10.1128/MCB.20.21.8018-8025.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  RB regulates the stability and the apoptotic function of p53 via MDM2.

Authors:  J K Hsieh; F S Chan; D J O'Connor; S Mittnacht; S Zhong; X Lu
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

Review 2.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

3.  Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.

Authors:  S Gorina; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

4.  Gas1-induced growth suppression requires a transactivation-independent p53 function.

Authors:  G Del Sal; E M Ruaro; R Utrera; C N Cole; A J Levine; C Schneider
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2.

Authors:  J P Yang; M Hori; N Takahashi; T Kawabe; H Kato; T Okamoto
Journal:  Oncogene       Date:  1999-09-16       Impact factor: 9.867

6.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

7.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

8.  The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M.

Authors:  L Naumovski; M L Cleary
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

9.  Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.

Authors:  N R Helps; H M Barker; S J Elledge; P T Cohen
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

10.  Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.

Authors:  J M Ford; P C Hanawalt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  10 in total

1.  A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.

Authors:  Assaf Friedler; Lars O Hansson; Dmitry B Veprintsev; Stefan M V Freund; Thomas M Rippin; Penka V Nikolova; Mark R Proctor; Stefan Rüdiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.

Authors:  Jinwoo Ahn; In-Ja L Byeon; Chang-Hyeock Byeon; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

3.  Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus.

Authors:  Sean M O'Donnell; Geoffrey H Holm; Janene M Pierce; Bing Tian; Melissa J Watson; Ravi S Chari; Dean W Ballard; Allan R Brasier; Terence S Dermody
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

5.  ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

Authors:  Kathryn Van Hook; Zhiping Wang; Dexi Chen; Casey Nold; Zhiyi Zhu; Pavana Anur; Hun-Joo Lee; Zhiyong Yu; Brett Sheppard; Mu-Shui Dai; Rosalie Sears; Paul Spellman; Charles D Lopez
Journal:  Biochem Biophys Res Commun       Date:  2016-12-08       Impact factor: 3.575

6.  Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.

Authors:  Kerstin M Kampa; Jared D Acoba; Dexi Chen; Joel Gay; Hunjoo Lee; Kelly Beemer; Emerson Padiernos; Nataya Boonmark; Zhiyi Zhu; Alice C Fan; Alexis S Bailey; William H Fleming; Christopher Corless; Dean W Felsher; Louie Naumovski; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

7.  Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.

Authors:  Ariel M Wilson; Vince A Chiodo; Sanford L Boye; Nicholas C Brecha; William W Hauswirth; Adriana Di Polo
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

8.  Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.

Authors:  Marcus M Schittenhelm; Barbara Illing; Figen Ahmut; Katharina Henriette Rasp; Gunnar Blumenstock; Konstanze Döhner; Charles D Lopez; Kerstin M Kampa-Schittenhelm
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

9.  Expression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 area.

Authors:  Vladimir O Pustylnyak; Pavel D Lisachev; Mark B Shtark
Journal:  Neural Plast       Date:  2015-02-12       Impact factor: 3.599

10.  ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.

Authors:  Minghua Lin; Yuan Chang; Fang Xie; Ying Shi; Lijun Pang; Dexi Chen
Journal:  Dig Dis Sci       Date:  2017-12-02       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.